Search Results 141-150 of 17160 for monoclonal antibody

1. Melphalan flufenamide (intravenous route) - Mayo Clinic

   ... monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent) that did not work well. Melphalan flufenamide belongs to the group of medicines ...

2. A Study of Nivolumab and Multi-fraction Stereotactic Radiosurgery with or without Ipilimumab in Treating Participants with Recurrent Grade II-III Meningioma - Mayo Clinic

   Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ... History of severe hypersensitivity reaction to any monoclonal antibody.

3. A Study to Evaluate Acalabrutinib With or Without Obinutuzumab to Treat Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients - Mayo Clinic

   Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

4. Colon Melanoma Clinical Trials

   Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

5. Clinical trials - Oncology (Medical)

   Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

6. Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Hard-to-Treat Multiple Myeloma - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as teclistamab, may help the body's immune system attack the cancer, and may interfere with the ability of cancer ...

7. A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma (iMMagine-3) - Mayo Clinic

   ... monoclonal antibody and an immunomodulatory drug. The primary objective of this study is to compare the efficacy of anitocabtagene autoleucel versus SOCT in ...

8. Clinical trials - Oncology (Medical)

   Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

9. Science Saturday: Collaborative study discovers new disease behind patient's recurring blood clots

   It occurs when an individual produces monoclonal antibodies (mAbs) to platelet factor 4 (PF4) leading to blood clots and low platelet counts. "MGTS is a ...

10. Clinical trials - Oncology (Medical)

    Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...